The goals of these studies are to determine the role of caveolin-1 in mammary tumorigenesis. The caveolin-1 protein is the essential component of caveolae organelles that regulates signal transduction pathways. Evidence suggesting caveolin-1 is a breast tumor suppressor includes: i) Caveolin-1 inhibits cellular proliferation and anti-sense caveolin-1 promotes contact independent growth of cultured 3T3 cells. ii) Caveolin-1 inhibits cyclin D1 breast cellular proliferation Cyclin D1 anti-sense can inhibit contact-independent growth of mammary tumor cell lines derived from the MMTV-ErbB2 transgenics in vivo). iii). Caveolin-1 levels are reduced in human and murine mammary tumors, including MMTV-ErbB2 derived tumors, and in the majority of breast cancer cell lines. iv). Loss of heterozygosity (LOH) analysis shows CAV1 is within the 7q31.1 region implicated to encode a breast tumor suppressor gene. We hypothesize that caveolin-1 inhibits mammary tumor growth repression of cyclin D1 and induction of the cyclin dependent kinase inhibitor p27. Reduced p27 levels and increased cyclin D1 correlates with poor prognosis in human breast cancer. p27 functions as a haplo- insufficient tumor suppressor of ErbB2-induced mammary tumorigenesis in vivo, transgenic mice, over-expressing caveolin-1 (beta-actin-CMV- enhancer-caveolin), or lacking the caveolin-1 gene (Cav-1/-) were generated. Both types of mice survive and breast feed. Mouse embryo fibroblasts (MEFs) of CAV-1 over-expressing transgenics show reduced cellular proliferation, and delayed S-phase entry and increased apoptosis. In contrast, MEFs derived from Cav-1-/- mice show enhanced cellular proliferation and S-phase entry and reduced cellular apoptosis. The proposed studies will 1). Determine the effect of caveolin-1 over- expression on Neu-induced mammary tumors. 2). Determine the effect of transgenic caveolin-1 on mammary tumor growth in vivo using MMTV- ErbB2 transgenic mice. 3). Determine if genetic ablation of the caveolin- 1 gene predisposes towards mammary tumorigenesis and metastasis in vivo.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
7R01CA093596-02
Application #
6620445
Study Section
Metabolic Pathology Study Section (MEP)
Program Officer
Sathyamoorthy, Neeraja
Project Start
2001-12-11
Project End
2006-11-30
Budget Start
2003-05-21
Budget End
2003-11-30
Support Year
2
Fiscal Year
2003
Total Cost
$277,138
Indirect Cost
Name
Georgetown University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
049515844
City
Washington
State
DC
Country
United States
Zip Code
20057
Di Vizio, Dolores; Sotgia, Federica; Williams, Terence M et al. (2007) Caveolin-1 is required for the upregulation of fatty acid synthase (FASN), a tumor promoter, during prostate cancer progression. Cancer Biol Ther 6:1263-8
Ozaki, Iwata; Zhang, Hao; Mizuta, Toshihiko et al. (2007) Menatetrenone, a vitamin K2 analogue, inhibits hepatocellular carcinoma cell growth by suppressing cyclin D1 expression through inhibition of nuclear factor kappaB activation. Clin Cancer Res 13:2236-45
Fu, Maofu; Liu, Manran; Sauve, Anthony A et al. (2006) Hormonal control of androgen receptor function through SIRT1. Mol Cell Biol 26:8122-35
Sotgia, Federica; Rui, Hallgeir; Bonuccelli, Gloria et al. (2006) Caveolin-1, mammary stem cells, and estrogen-dependent breast cancers. Cancer Res 66:10647-51
Wang, Chenguang; Li, Zhiping; Lu, Yinan et al. (2006) Cyclin D1 repression of nuclear respiratory factor 1 integrates nuclear DNA synthesis and mitochondrial function. Proc Natl Acad Sci U S A 103:11567-72
Gong, J; Zhu, J; Goodman Jr, O B et al. (2006) Activation of p300 histone acetyltransferase activity and acetylation of the androgen receptor by bombesin in prostate cancer cells. Oncogene 25:2011-21
Hulit, James; Lee, Richard J; Li, Zhiping et al. (2006) p27Kip1 repression of ErbB2-induced mammary tumor growth in transgenic mice involves Skp2 and Wnt/beta-catenin signaling. Cancer Res 66:8529-41
Sakamaki, Toshiyuki; Casimiro, Mathew C; Ju, Xiaoming et al. (2006) Cyclin D1 determines mitochondrial function in vivo. Mol Cell Biol 26:5449-69
Cui, Yukun; Niu, Airu; Pestell, Richard et al. (2006) Metastasis-associated protein 2 is a repressor of estrogen receptor alpha whose overexpression leads to estrogen-independent growth of human breast cancer cells. Mol Endocrinol 20:2020-35
Li, Zhiping; Wang, Chenguang; Jiao, Xuanmao et al. (2006) Cyclin D1 regulates cellular migration through the inhibition of thrombospondin 1 and ROCK signaling. Mol Cell Biol 26:4240-56

Showing the most recent 10 out of 24 publications